Durable Response to Sintilimab and Chidamide in a Patient With Pegaspargase- and Immunotherapy-Resistant NK/T-Cell Lymphoma: Case Report and Literature Review

The prognosis of patients with relapsed/refractory NK/T-cell lymphoma (NKTCL) is dismal. Immunotherapy has showed encouraging anti-tumor activity in patients with asparaginase-resistant NKTCL; however, only a portion of patients benefit and the median response duration is rather short. Treatment str...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zheng, Yao, Shuna, Liu, Yanyan, Zhang, Jianbo, Li, Peng, Wang, Haiying, Chu, Junfeng, Zhao, Shuang, Yao, Zhihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759664/
https://www.ncbi.nlm.nih.gov/pubmed/33363038
http://dx.doi.org/10.3389/fonc.2020.608304

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759664/
https://www.ncbi.nlm.nih.gov/pubmed/33363038
http://dx.doi.org/10.3389/fonc.2020.608304

Ejemplares similares